Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Political Intelligence

Political Intelligence is an independent European public affairs consultancy, with offices in London, Brussels, Madrid, Edinburgh and Rome.  We provide our clients with practical public affairs advice that helps them to achieve their business objectives. Our professional and dedicated consultancy service includes political monitoring & intelligence, stakeholder engagement programmes, political and policy research, strategic advice, event management and public affairs training. With our interdisciplinary team we deliver a comprehensive public affairs service throughout the EU.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Health policy and government affairs, Market access, Market research

Company Details

Political Intelligence
69 Wilson Street, London, EC2A 2BB, United Kingdom
+44 (0)20 3397 3300
Contact Political Intelligence
Website

 Latest Content from PMHub 

Not waving but drowning. Reflections on data curation in the age of information overload

White Papers and Resources | December 3, 2020 | Porterhouse Medical Group

As of October 2019 there were over 300,000 clinical studies registered worldwide, compared to just over 2,100 in the year 2000’It’s common to hear colleagues and friends bemoan the huge...

The patient journey: A long and winding road

Press Releases | December 3, 2020 | Porterhouse Medical Group

Reflections of a research executive

Webcast

White Papers and Resources | November 30, 2020 | Inizio

The power of a good story: Turn your insights into effective storytelling with data visualisation

Importance of Patient Advocacy in Improving Healthcare

Videos and Podcasts | November 26, 2020 | Impetus Digital

Eva Villalba, Executive Director of the Quebec Cancer Coalition, explores the importance of patient advocacy in improving healthcare. Among many other things, we dive into how the industry can help support...

Improving Patient Care by Removing Barriers to Drug Accessibility

Videos and Podcasts | November 26, 2020 | Impetus Digital

Alan Birch, Founder & President of Drug Access Canada, discusses all things drug access and reimbursement. Among many other things, we explore the hurdles faced by patients and drug access navigators and...

Reimagining the Patient Journey

Videos and Podcasts | November 26, 2020 | Impetus Digital

Kimberly Tableman, CEO at Medicine X, discusses a myriad of topics related to digital transformation and patient centricity, including how digital health technologies can be used to reimagine the patient...

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health

White Papers and Resources | November 26, 2020 | OPEN Health

If the heart of the medical affairs industry is ultimately improving patient outcomes, internal training is the regenerative liver. Med affairs professionals need to regularly update their scientific knowledge and...

Environmental impact of in-person vs. virtual meetings

White Papers and Resources | November 26, 2020 | Impetus Digital

Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...

Harness the power of data to map new patient pathways

White Papers and Resources | November 24, 2020 | Wilmington Healthcare

Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset

What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health

White Papers and Resources | November 24, 2020 | OPEN Health

How fantastic is it to see that the National Organisation for Rare Disorders (NORD) has followed up on a survey undertaken in the late 80’s to pressure test progress and identify...